Vincent Ippolito
Chairman bei BOTANIX PHARMACEUTICALS LIMITED
Vermögen: 2 Mio $ am 31.03.2024
Profil
Vincent Peter Ippolito is currently the Executive Chairman & President at Botanix Pharmaceuticals Ltd.
and Botanix Pharmaceuticals, Inc. He is also the Director at Suneva Medical, Inc. Previously, he held positions such as Chief Commercial Officer, EVP-Sales & Marketing at Medicis Pharmaceutical Corp.
from 2003 to 2014, Vice President-Sales at Novartis AG in 2003, Chief Commercial Officer & Executive VP at Anacor Pharmaceuticals LLC from 2014 to 2017, and President & Chief Operating Officer at Dermavant Sciences, Inc. from 2017 to 2019.
Mr. Ippolito received his undergraduate degree from the University of Wisconsin-Eau Claire.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2023 | 10 801 644 ( 0,69% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Vincent Ippolito
| Unternehmen | Position | Beginn |
|---|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Chairman | 18.07.2019 |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Director/Board Member | 28.08.2017 |
Botanix Pharmaceuticals, Inc.
 Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Botanix Pharmaceuticals, Inc. develops therapeutics for the treatment of serious skin diseases. Its products include BTX1503-Acne, BTX1308-Plaque Psoriasis, and BTX1204-Atopic Dermatitis. The company is headquartered in Plymouth Meeting, PA. | Chairman | 01.07.2019 |
Ehemalige bekannte Positionen von Vincent Ippolito
| Unternehmen | Position | Ende |
|---|---|---|
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | President | 01.01.2019 |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 30.09.2017 |
| MEDICIS PHARMACEUTICAL CORP | Sales & Marketing | 01.03.2014 |
| NOVARTIS AG | Sales & Marketing | 02.01.2003 |
| BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | - |
Ausbildung von Vincent Ippolito
| University of Wisconsin-Eau Claire | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| BAUSCH HEALTH COMPANIES INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Technology |
Botanix Pharmaceuticals, Inc.
Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Botanix Pharmaceuticals, Inc. develops therapeutics for the treatment of serious skin diseases. Its products include BTX1503-Acne, BTX1308-Plaque Psoriasis, and BTX1204-Atopic Dermatitis. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
